Author： Drakeman D.L. Wallace P.K.
Publisher： Informa Healthcare
ISSN： 1472-8214
Source： Expert Opinion on Emerging Drugs, Vol.4, Iss.1, 1999-01, pp. : 355-365
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Monoclonal Antibodies in Solid Tumours
Current Clinical Pharmacology, Vol. 5, Iss. 3, 2010-08 ,pp. :
Access to resources
Recommend
Monoclonal Antibodies - Regulatory Challenges
Current Pharmaceutical Biotechnology, Vol. 9, Iss. 6, 2008-12 ,pp. :
Monoclonal Antibodies as Innovative Therapeutics
Current Pharmaceutical Biotechnology, Vol. 9, Iss. 6, 2008-12 ,pp. :
Toxin-Labeled Monoclonal Antibodies
Current Pharmaceutical Biotechnology, Vol. 2, Iss. 4, 2001-12 ,pp. :
Monoclonal Antibodies: A Review
Current Clinical Pharmacology, Vol. 13, Iss. 2, 2018-05 ,pp. :